Table 2.
Clinical and laboratory characteristics of KS patients and control.
| KS (n = 85) | Control (n = 75) | P value | |
|---|---|---|---|
| Age (years) | 30.75 ± 6.93 | 30.25 ± 8.96 | 0.6901 |
| BMI (kg/m2) | 27.23 ± 4.12 | 22.8 ± 2.61 | <0.001* |
| Diabetes mellitus | 5(5.9%) | 0(0.0) | 0.061 |
| Hypertension | 3(3.5%) | 0(0.0) | 0.248 |
| History of previous thrombosis | 0(0.0) | 0(0.0) | – |
| History of varicose veins | 6(7.1%) | 2(2.7%) | 0.284 |
| Fasting blood sugar (mg/dl) | 88.7 ± 4.5 | 85.6 ± 2.5 | <0.001* |
| Systolic blood pressure (mmHg) | 135 ± 22 | 96 ± 20 | <0.001* |
| Diastolic blood pressure (mmHg) | 88 ± 8.71 | 87.5 ± 11 | 0.749 |
| Serum cholesterol (mg/dl) | 190.6 ± 17.2 | 156.5 ± 13.36 | <0.001* |
| Serum triglycerides (mg/dl) | 139.2 ± 16.1 | 87.6 ± 14 | <0.001* |
| LDL (mmol/l) | 117.6 ± 18.2 | 92.1 ± 13.2 | <0.001* |
| HDL (mmol/l) | 15.8 ± 7.6 | 24.5 ± 9.3 | <0.001* |
| Testosterone (ng/ml) | 1.08 ± 0.25 | 6.04 ± 2.30 | <0.001* |
| FSH (mIU/ml) | 23.7 ± 2.5 | 3.74 ± 0.21 | <0.001* |
| LH (mIU/ml) | 20.3 ± 1.5 | 3.39 ± 0.25 | <0.001* |
| Estradiol (pmol/L) | 116.4 ± 8.52 | 122.1 ± 6.45 | <0.0001* |
BMI: Body mass index, LDL: Low density lipoprotein, HDL: High density lipoprotein, FSH: Follicle stimulating hormone, LH: Luteinizing hormone.
*Statistically significant at p < 0.05.